1,3-dipropyl-8-cyclopentylxanthine has been researched along with 11-cis-retinal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dice, A; Dineen, B; Dunwiddie, TV; Gilchrist, A; Hamm, HE; Linden, J; Lupica, CR; Mazzoni, MR; Proctor, WR | 1 |
| Catarzi, D; Ciampi, O; Colotta, V; Filacchioni, G; Lenzi, O; Martini, C; Morizzo, E; Moro, S; Pedata, F; Pugliese, AM; Traini, C; Trincavelli, L; Varano, F | 1 |
2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and 11-cis-retinal
| Article | Year |
|---|---|
Antagonists of the receptor-G protein interface block Gi-coupled signal transduction.
Topics: Adenosine; Animals; Baclofen; Binding, Competitive; Brain; Cells, Cultured; Electrophysiology; GTP-Binding Proteins; Humans; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, Purinergic P1; Rhodopsin; Signal Transduction; Xanthines | 1998 |
Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Topics: Adenosine A3 Receptor Antagonists; Animals; Binding, Competitive; Brain Ischemia; Cattle; Cell Membrane; Cerebral Cortex; Disease Models, Animal; Humans; Hydrogen Bonding; Ligands; Models, Molecular; Protein Binding; Quinoxalines; Rats; Receptor, Adenosine A3; Rhodopsin; Structural Homology, Protein; Structure-Activity Relationship; Triazoles; Xanthines | 2008 |